Cost-effectiveness and budget impact of the fixed-dose dual bronchodilator combination tiotropium-olodaterol for patients with COPD in the Netherlands. [electronic resource]
Producer: 20170809Description: 2191-2201 p. digitalISSN:- 1178-2005
- Adrenergic beta-2 Receptor Agonists -- economics
- Aged
- Benzoxazines -- economics
- Bronchodilator Agents -- economics
- Budgets
- Cholinergic Antagonists -- economics
- Cost-Benefit Analysis
- Disease Progression
- Drug Combinations
- Drug Costs
- Female
- Forced Expiratory Volume
- Humans
- Lung -- drug effects
- Male
- Markov Chains
- Medication Adherence
- Middle Aged
- Models, Economic
- Netherlands
- Pulmonary Disease, Chronic Obstructive -- drug therapy
- Quality-Adjusted Life Years
- Severity of Illness Index
- Time Factors
- Tiotropium Bromide -- economics
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.